期刊文献+

四联疗法根除幽门螺旋杆菌的临床效果观察 被引量:5

Clinical effect observation of quadruple therapy for eradication of Helicobacter pylori
原文传递
导出
摘要 目的观察四联疗法根除幽门螺旋杆菌的临床效果。方法选择某院2010年5月~2013年5月幽门螺旋杆菌阳性患者82例,随机数字分为观察组和对照组,每组41例。观察组用四联疗法(奥美拉唑、阿莫西林、左氧氟沙星、丽珠得乐)治疗,对照组用三联疗法(奥美拉唑、克拉霉素、左氧氟沙星)治疗,疗程均为14 d,治疗结束4周后复查,比较两组根除幽门螺旋杆菌的治疗效果。结果观察组幽门螺旋杆菌根除率为95.12%,明显高于对照组的80.49%(χ2=4.11,P﹤0.05)。结论四联疗法根除幽门螺旋杆菌的临床效果好,值得临床应用推广。 Objective To observe the clinical effect of quadruple therapy for eradication of Helicobacter pylori.Methods From May 2010 to May 2013,82 cases of Helicobacter pylori positive patients were randomly divided into observation group and control group,41 cases in each group.The observation group in the treatment of(quadruple therapy of omeprazole,amoxicillin,levofloxacin,Livzon dele);control group in the treatment of(triple therapy with omeprazole,clarithromycin,levofloxacin).The treatment both lasted for 14 days,around check after the end of treatment,compared two groups of eradication Helicobacter pylori treatment.Results The eradication rate of Hpylori in the observation group was 95.12%,significantly higher than that in the control group of 80.49%(χ2= 4.11,P〈0.05).Conclusion The clinical effect of quadruple therapy for eradication of Helicobacter pylori is good,it is worthy of clinical application.
出处 《医学动物防制》 2016年第6期697-699,共3页 Journal of Medical Pest Control
关键词 四联疗法 根除幽门螺旋杆菌 临床效果观察 Quadruple therapy Helicobacter pylori eradication Clinical observation
  • 相关文献

参考文献8

二级参考文献37

  • 1周丽雅,薛艳,林三仁,孟灵梅,李传凤,闫秀娥,高娜,王琨,段卓洋.北京地区25年来消化性溃疡及胃癌发病情况的演变[J].中华内科杂志,2005,44(6):431-433. 被引量:33
  • 2成虹,胡伏莲.北京地区幽门螺杆菌耐药情况及其变化趋势[J].中华医学杂志,2005,85(39):2754-2757. 被引量:176
  • 3中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. 被引量:835
  • 4Mine T, Muraoka H, Saika T, et al. Characteristics of a clinical isolate of urease-negative Helicobacter pylori and its ability to induce gastric ulcers in Mongolian gerbils. Hellcobacter, 2005,10:125-131.
  • 5Ford AC, Delaney BC, Forman D, et al. Eradication therapy for peptic ulcer disease in Helicohacter pylori positive patients. Cochrane Database Syst Rev, 2006,2: CD003840.
  • 6Egan BJ, Katicie M, O'Connor HJ, et al. Treatment of Helicobacter pylori. Helicobacter, 2007,12 : 31-37.
  • 7De Francesco V, Margiotta M, Zullo A J, et al. Prevalence of primary clarlthromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimlcrob Chemother, 2007, 59: 783-785.
  • 8Kobayashi I, Murakaml K, Kato M, et al. Changing antimicrobial susceptibility epidemiology of Hellcobacter pylorl strains in Japan between 2002 and 2005. J Clin Microbiol, 2007,45: 4006-4010.
  • 9Gisbert JP, Oisbert JL, Marcos S, et al. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther, 2008,27 : 346354.
  • 10Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2000,14: 715-718.

共引文献199

同被引文献34

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部